September 2015

  • Client : DB Ashbourne Limited
  • Activity : Provider of off-patent branded pharmaceuticals for the UK market
  • Sector : Healthcare
  • Acquired by: Ethypharm S.A.
  • Transaction Type:

What our clients say

  • Thank you so much for your efforts and teamwork in selling RPS! Your approach and process was vital to our successful sale of the Company. In particular, the initiation of a excellent and professional process enabled us to get the actual sales process launched and resourced effectively, which facilitated the smooth initiation of selling discussions in a thorough...

    Adrienne MacMillan | CFO Rapidscan Pharm Solutions Inc
  • The Cavendish Team, led by Michael Jewell, did an excellent job managing a well-orchestrated auction process and ensuring the smooth closing of the transaction in a timely manner. They were professional and easy to deal with throughout and committed to achieving a successful outcome for the...

    Rhian Griffith | Representative of the Shareholders at SG Court
  • ‘The Cavendish team were of great assistance throughout the sale process and in particular finding us the most fitting acquirer, helped by their strong networks in healthcare and their understanding of the oral care...

    Richard Benholt | Managing Director of Periproducts
  • At this critical stage in the business it has been important that we make all of the right decisions along the way and appointing Cavendish was one of these key decisions. We have worked with very professional and motivated individuals in Anya, Fiona, Jonathan and Duncan on various stages of the process. We look forward to working with the Cavendish team again as our business develops toward our...

    Julian Shovlin | Founder and CEO of iSmash
  • “Cavendish were a fantastic partner for World First throughout the investment process. We were impressed with their knowledge, level of service and professionalism and we are very excited about working with FTV to realise our growth...

    Neil Sikka | Founder Barbican Dental Care
  • “Gordon and Mike have built a strong relationship with the shareholders over the last three years, helping us to identify the right potential strategic partner and clearly articulating the strategic...

    Alan Cheshire | Former Chairman and a Founding Shareholder of Polar Speed
  • Cavendish were a great adviser throughout the process. They knew how to handle whatever situation occurred and the team were a total pleasure to work with. Thanks to their involvement, we drew a successful conclusion to the deal....

    Alex Farrel | Managing Director of The IT Job Board
  • “I wanted to express my personal thanks to you for all your efforts in achieving a successful sale of Yorktest. I never knew how stressful and complex the sale process could be. I really do appreciate your finding a good deal in quite difficult...

    John Graham|Former Chairman of Yorktest
  • “Cavendish’s Exit Review allowed us to align and mobilize all stakeholders on the key priorities that have the most impact on valuation over a 6-18 month period – a very valuable...

    Terry Lee|Chairman, SENAD

Cavendish Leads on the Sale of Off-Patent Branded Pharmaceuticals Provider DB Ashbourne to Top French Pharmaceutial Company Ethypharm.

Key Contacts

Other deals in Healthcare